BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

HOWL

Werewolf Therapeutics, Inc.
Nasdaq · Pharmaceutical preparations (SIC 2834) · FY ends 31 Dec
PeersSuggested peers share the same SIC code and have similar revenue. Add or remove any of them.
TLPHATOSTCRTRLMD5 of 12 companies
Columns
Market cap †Revenue (TTM)Revenue growthGross marginOperating marginP/S †P/E †7 of 8
HOWLWerewolf Therapeutics, Inc.(opens in a new tab)$0.05B——————
TLPHTalphera, Inc.(opens in a new tab)—$0.00B−96.3%−486.2%−1474700.0%——
ATOSAtossa Therapeutics, Inc.(opens in a new tab)$0.02B$0.00B−35.2%−93026.9%———
TCRTAlaunos Therapeutics, Inc.(opens in a new tab)$0.00B$0.00B−50.0%—−135266.7%1617.08×—
RLMDRelmada Therapeutics, Inc.(opens in a new tab)$0.40B——————
Medianpeers, excl. HOWL$0.02B$0.00B−50.0%−46756.6%−804983.3%1617.08×—
Fundamentals: company filings, trailing twelve months as of each latest report. † Price-based columns: last sale on IEX, prior session 30 Oct, ÷ TTM as filed; “—” when a price is more than a week old or a figure isn’t meaningful. Click any column header to sort; click again to reverse. Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.vpside.com